PARI Respiratory Equipment, Midlothian, Va, introduces a new device that provides positive expiratory pressure (PEP) that can be used with all PARI LC reusable nebulizers. According to PARI, the PEP S can be used alone or in combination with nebulizer therapies for airway clearance and lung strengthening exercises by cystic fibrosis (CF) patients. The PEP S has eight adjustable resistance settings, covering a large expiratory flow range while achieving optimal resistance rates.
"I believe the new PARI PEP S is an incredible new device that improves patient care in two very important areas. It reduces treatment time by combining the PEP procedure with needed nebulized treatments. It may also enhance medication deposition with effective airway clearance during the nebulized treatment, especially in patients that find other modes of airway clearance cumbersome," said Sterling Simpson, MD, pediatric pulmonologist, East Tennessee Children’s Hospital.
"PARI is continually striving to improve respiratory therapies, and the PEP S is a time saver for cystic fibrosis patients. The PEP S allows for combination therapy with all of our LC reusable nebulizers, including the LC Sprint," said Geoff A. Hunziker, president of PARI Respiratory Equipment.